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Introduction
The majority of solid tumors contain regions of hypoxia as a   
result of their poor local vasculature (Pouysségur et al., 2006). 
The hypoxia inducible factor 1 (HIF-1) is the master regulator 
of the cell’s response to low-oxygen tension that controls the 
transcription of >100 genes essential for hypoxic adaptation, 
angiogenesis, invasion, and tumor progression (Semenza and 
Wang, 1992; Semenza, 2003). HIF-1, the oxygen-regulated 
subunit of HIF-1, is found overexpressed in >70% of all human 
tumors, and its expression is correlated with poor prognosis and 
resistance to therapy. Therefore, inhibition of HIF-1 represents 
an attractive strategy for anticancer therapy.
The availability of HIF-1 protein under different envi-
ronmental conditions is tightly controlled though protein syn-
thesis  and  degradation.  The  oxygen-dependent  proteasomal 
degradation of HIF-1, mediated primarily by the von Hippel 
Lindau protein (pVHL), is a well-characterized pathway, and it 
is widely accepted that inhibition of pVHL results in HIF-1 
protein accumulation during hypoxia (Jaakkola et al., 2001).   
In contrast to the inhibition of global protein synthesis that   
occurs in the absence of oxygen (Guppy et al., 2005), HIF-1 
translation continues unobstructed under hypoxia, contributing 
to the increase in HIF-1 protein and transcriptional activity. 
Although the pathways involved in HIF-1 protein stability and 
degradation are well characterized, little is known about the 
regulation of HIF-1 translation, hindering the potential thera-
peutic exploitation of the latter mechanism.
In this study, we report a new mechanism of HIF-1 trans-
lational regulation that requires the presence of functional micro-
tubules. The microtubule cytoskeleton is an extensive network 
of filaments that undergoes constant remodeling according to 
its role in diverse cellular functions, ranging from cell division 
to intracellular trafficking. These features make microtubules 
attractive targets for cancer therapy, as indicated by the broad 
clinical use of existing microtubule-targeting drugs (MTDs), 
such as taxanes and vinca alkaloids, and the large number   
of  new  MTDs  in  development  (Jordan  and Wilson,  2004;   
Kavallaris, 2010). Unlike conventional thinking supporting inhi-
bition of mitosis as the predominant mechanism of MTD action, 
the slow growth of human tumors (Skipper, 1971) together with 
the increasing body of literature showing mitosis-independent cell 
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expressed  in  solid  tumors,  driving  tumor  angio-
genesis  and  survival.  However,  the  mechanisms 
regulating  HIF-1  expression  in  solid  tumors  are  not 
fully understood. In this study, we find that microtubule 
integrity  and  dynamics  are  intricately  involved  in  or-
chestrating HIF-1 translation. HIF-1 messenger RNA 
(mRNA)  traffics  on  dynamic  microtubules  when  it  is 
actively  translated.  Microtubule  perturbation  by  taxol 
(TX) and other microtubule-targeting drugs stalls HIF-1  
mRNA transport and releases it from polysomes, sup-
pressing its translation. Immunoprecipitation of the P-body 
component Argonaute 2 (Ago2) after microtubule dis-
ruption shows significant enrichment of HIF-1 mRNAs 
and  HIF-targeting  microRNAs  (miRNAs).  Inhibition  of 
HIF-repressing miRNAs or Ago2 knockdown abrogates 
TX’s ability to suppress HIF-1 translation. Interestingly, 
microtubule repolymerization after nocodazole wash-
out allows HIF-1 mRNA to reenter active translation, 
suggesting that microtubule dynamics exert tight yet re-
versible control over HIF-1 translation. Collectively, we 
provide evidence for a new mechanism of microtubule-
dependent  HIF-1  translation  with  important  implica-
tions for cell biology.
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normoxia (55%). Treatment with all of the MTDs resulted in 
a shift of HIF-1 mRNA from active to inactive translation, 
which is consistent with the ability of each MTD to efficiently 
disrupt cellular microtubules (Fig. 1 A, top) and down-regulate 
HIF-1 protein (Fig. 1 C). No shift was observed in the transla-
tion status of unrelated messages such as GAPDH (Fig. 1 B), 
HIF-1, actin (not depicted), or the transcription factor p53 
(Fig. 1 B). The latter is an important control, as we have previ-
ously shown that p53 protein utilizes microtubules for its   
nuclear targeting; however, in contrast to HIF-1, microtubule 
disruption had no effect on p53 protein expression (Giannakakou 
et al., 2000, 2002). The polysome profile of HIF-1 was also   
altered by MTDs in MDA-MB-231 breast cancer cells and   
PC3 prostate cancer cells (unpublished data), suggesting that 
the drug-induced inhibition of HIF-1 translation is not cell 
type dependent.
Inhibition of HIF-1 translation occurs 
downstream of microtubule disruption
To further investigate whether the inhibition of HIF-1 trans-
lation is dependent on chemomechanics of the microtubule cyto-
skeleton, we used the TX-resistant human ovarian carcinoma 
cell  line  1A9/PTX10,  which  was  previously  established  in 
our laboratory. These cells harbor an acquired -tubulin mu-
tation (F270V) at the taxane-binding site (Giannakakou et 
al.,  1997)  that  prevents  drug–target  interaction. We  treated 
parental 1A9 and 1A9/PTX10 cells with TX and assessed the 
polysome association profile of HIF-1 as described in Fig. 1. 
TX treatment led to the association of 71% of HIF-1 mRNA 
with the nontranslating ribosomal subunits consistent with the 
TX-induced inhibition of HIF-1 protein (Fig. 2 A, bottom) 
in 1A9 cells. In contrast, TX treatment did not affect HIF-1 
translation in 1A9/PTX10 cells, as >90% of HIF-1 mRNA 
was associated with translating polysomes in both untreated 
and treated cells (Fig. 2 B and Table I). These results were 
corroborated by the lack of TX-induced microtubule stabiliza-
tion (Fig. S1 A) and HIF-1 protein inhibition in 1A9/PTX10 
cells (Fig. 2 B). Collectively, these findings indicate that effi-
cient drug–tubulin interaction is required for the inhibition of 
HIF-1 translation.
To rule out the possibility that these results were appli-
cable to TX alone or to the specific pair of parental and drug-
resistant cell lines, we developed a cell line resistant to the 
microtubule-depolymerizing  drug  2ME2  (1A9/2MRC). The 
1A9/2MRC  cells  acquired  a  different  -tubulin  mutation 
(V236I) that impairs 2ME2 binding and renders these cells 
>80-fold resistant to 2ME2 (Escuin et al., 2009). Treatment 
with 2ME2 inhibited HIF-1 translation in 1A9 cells (Fig. 2 C) 
but had no effect in 1A9/2MRC cells (Fig. 2 D and Table I), 
which is consistent with 2ME2’s inability to inhibit HIF-1 
protein in these cells (Fig. 2 D). This result is consistent with 
the lack of 2ME2-mediated microtubule depolymerization in 
1A9/2MRC cells (Fig. S1 A; Escuin et al., 2009) and further 
supports the notion that microtubule disruption is required for 
and precedes HIF-1 translation inhibition. No effect on the 
protein levels or polysome association of GAPDH (Fig. 2) or 
p53 (not depicted) was observed after MTD treatment in any 
kill by MTDs (Giannakakou et al., 2000; Mabjeesh et al., 2003; 
Gascoigne and Taylor, 2008) suggest that the antitumor activ-
ity of this class of drugs can also be attributed to their effects 
in interphase. However, the pathways regulated by interphase 
microtubule dynamics in epithelial cancer biology are poorly 
understood. Understanding these pathways may help elucidate 
mechanisms of resistance to MTDs and provide important in-
sights into the selection of tumor types and/or individual patients 
most likely to benefit from this class of chemotherapeutics.
In this study, we provide evidence that taxol (TX) and 
other MTDs shift the association of HIF-1 mRNA from ac-
tively translating polysomes to translationally inactive ribo-
somal subunits. This change in HIF-1 polysome association 
occurs downstream of microtubule disruption, as the presence 
of a tubulin mutation in either the taxane- or 2-methoxyestradiol 
(2ME2)–binding site prevented the drug-induced changes. 
Using  molecular  beacons  (MBs)  to  visualize  endogenous   
HIF-1 mRNA in living cells, we showed that HIF-1 transla-
tion requires active transport of HIF-1 mRNA on interphase   
microtubules. Microtubule perturbation targeted HIF-1 mRNA   
to the P-body component Ago2, where HIF-repressing microRNAs 
(miRNAs) were also recruited. Microtubule repolymerization 
reversed this process and enabled HIF-1 mRNA to reenter 
active translation. Moreover, inhibition of endogenous HIF-
targeting  miRNAs  abrogated  the  ability  of TX  to  suppress 
HIF-1, suggesting an important role for miRNA machinery 
in the microtubule-dependent regulation of HIF-1 transla-
tion. In addition, knockdown (KD) of Ago2 also counteracted 
TX’s effect on HIF translation, highlighting the importance of 
the P-body component for this mechanism of action. Further 
elucidation of this mechanism will not only provide impor-
tant insights into the role of microtubules in the regulation 
of protein translation in epithelial cell biology but will also 
provide opportunities to specifically target HIF-1 translation 
for cancer therapy.
Results
MTDs inhibit HIF-1 translation
We have previously shown that TX, 2ME2, and other MTDs   
exert their antiangiogenic effects by inhibiting HIF-1 protein 
expression and transcriptional activation of HIF target genes, 
including VEGF (Mabjeesh et al., 2003; Escuin et al., 2005). 
However, the mechanism underlying the drug-induced HIF-1 
inhibition was unknown. To investigate whether microtubule 
disruption inhibited HIF-1 translation, we treated MCF7 cells 
with TX, vinblastine, or 2ME2 and assessed the polysome asso-
ciation profile of HIF-1 after sucrose gradient centrifugation. 
In this assay, we divided each gradient into 12 equal-volume 
fractions  and  monitored  the  position  of  nontranslating  ribo-
somal subunits (1–6) or translationally active polysomes (7–12) 
with continuous A254 measurements (Fig. 1 A). The amount of 
HIF-1 mRNA in each fraction was quantified by quantitative 
RT-PCR (qRT-PCR), and its distribution between translating 
and nontranslating fractions is shown in Fig. 1 B. In untreated 
cells, the majority of HIF-1 mRNA cofractionated with ac-
tively translating polysomes under both hypoxia (74%) and 85 Microtubule dynamics regulate HIF-1 translation • Carbonaro et al.
Figure 1.  MTDs inhibit HIF-1 translation. (A) Polysome association profile of MCF7 cells after overnight treatment with 25 nM TX, 25 nM vinblastine 
(VBL), or 25 µM 2ME2 visualized after sucrose gradient centrifugation. The 40, 60, and 80S ribosomal subunits and polysomes were fractionated and mon-
itored with continuous A254 measurements. Representative profiles and microtubule images after each drug treatment are shown. Bar, 10 µm. (B) RNA was 
extracted from each fraction, and HIF-1, GAPDH, and p53 expression was quantified by qRT-PCR. The distribution of each mRNA between nontranslating 
(1_6) and translating (7_12) fractions is plotted (mean ± SEM; n = 3–10; ***, P < 0.001). (C) Immunoblot of HIF-1 and actin from MCF7 cells treated as 
in A and exposed to normoxia (N) or 4-h hypoxia to visualize HIF-1 protein. Black lines indicate that intervening lanes have been spliced out.JCB • VOLUME 192 • NUMBER 1 • 2011   86
Figure 2.  Microtubule disruption is required for drug-induced inhibition of HIF-1 translation. (A and B) Parental 1A9 (A) and 1A9/PTX10 (B) cells 
treated with 10 nM TX overnight and subjected to sucrose gradient fractionation. The percentage of HIF-1 or GAPDH mRNA/fraction is plotted for each 
cell line and drug treatment. (bottom) HIF-1 and GAPDH protein levels in 1A9 (A) and 1A9/PTX10 (B) cells treated with 10 nM TX overnight assessed by 
immunoblotting after 4-h hypoxia. (C and D) Similar experiments performed using 1A9 (C) or 1A9/2MRC (D) cells to assess the HIF-1 polysome profile 
after 10 µM 2ME2 treatment. (bottom) Immunoblot of HIF-1 and GAPDH after 4-h hypoxia (Table I).87 Microtubule dynamics regulate HIF-1 translation • Carbonaro et al.
observed for either MB (Fig. S2 C and Video 5). Collectively, these 
results reveal that HIF-1 mRNA associates with and traffics   
on microtubules in epithelial cancer cells.
HIF-1 mRNA coprecipitates with tubulin
To further confirm the interaction between tubulin and HIF-1 
mRNA, we performed coprecipitations using MCF7–GFP-tub 
cells or MCF7–GFP mock cells as a negative control. Cell lysates 
treated with 2ME2, TX, or DMSO were subjected to anti-GFP   
immunoprecipitation. Bound RNA was extracted from each con-
dition, and HIF-1, p53, and GAPDH mRNA expression was 
quantified by qRT-PCR. Our results showed that HIF-1 mRNA 
was specifically bound to tubulin, as neither p53 nor GAPDH 
mRNA coprecipitated with microtubules (Fig. 3 D), and no 
bound  mRNAs  were  identified  in  immunoprecipitates  from 
MCF7–GFP mock cells (Fig. S2 F). Microtubule depolymerization 
by 2ME2 at concentrations that effectively inhibited HIF-1 pro-
tein levels (Fig. S2 D) resulted in dissociation of HIF-1 mRNA 
from tubulin, confirming our earlier observations using HIF-1 
MBs (Fig. 3 D). In contrast, HIF-1 mRNA remained bound to 
microtubules after TX treatment (Fig. 3 D), which is consistent 
with our results in Fig. 3 C, where HIF-1 MBs remained associ-
ated with TX-induced microtubule bundles. No change in total 
RNA levels of HIF-1, p53, or GAPDH was observed after MTD 
treatment (Fig. S2 E). Our results suggest that mRNA–tubulin 
binding alone is not sufficient to regulate HIF-1 translation but, 
rather, that the integrity and dynamics of the microtubule cyto-
skeleton are important for regulation of HIF-1 translation.
Microtubule disruption induces  
P-body formation
To understand how microtubule integrity regulates HIF-1 trans-
lation, we further examined the significance of the increased 
80S  monosomal  peak  that  was  consistently  observed  in  the 
polysome profiles after MTD treatment (Fig. 1 A). We showed 
that this MTD-induced 80S increase was absent in traces from 
the two tubulin mutant cell lines (1A9/2MRC and 1A9/PTX10), 
suggesting that efficient microtubule disruption was causal to 
this effect (Fig. S1 C). This increase in 80S peak has been pre-
viously associated with inhibition of translation initiation after 
exposure to translation inhibitors, glucose starvation, and heat 
shock (Ashe et al., 2000; Low et al., 2005; Teixeira et al., 2005; 
Luke et al., 2007; Sivan et al., 2007). Furthermore, these 80S peaks 
are known to contain protein components of P-bodies and stress 
cell line. Collectively, our results show that both microtubule 
stabilization and depolymerization act as triggers for HIF-1 
translational repression.
HIF-1 mRNA colocalizes with the 
microtubule cytoskeleton
The  inhibition  of  HIF-1  translation  after  MTD  treatment 
prompted us to investigate the spatial relationship between HIF-1 
mRNA and cytoplasmic microtubules. To visualize HIF-1 
mRNA, we designed HIF-1–specific MBs, single-stranded 
oligonucleotides (ODNs) labeled with a 5 Texas red fluoro-
phore and a 3 quencher. In the absence of target mRNA, MBs 
form a hairpin and are devoid of fluorescence because of the 
proximity of the fluorophore and quencher. Upon hybridiza-
tion with its target, the hairpin opens, resulting in fluorescence   
(Fig. S2, A and B; Tyagi and Kramer, 1996; Bratu et al., 2003). 
We first examined the specificity of our MBs in vitro and ob-
served a more than threefold increase in fluorescence intensity 
after coincubation with a complementary sequence or total RNA 
from HIF-1–expressing cells. In contrast, only background 
fluorescence was observed upon coincubation with a sense DNA 
ODN (Fig. 3 A). We next evaluated the subcellular localization 
of HIF-1 mRNA by hybridizing the MB with fixed MCF7 cells 
stably  expressing  EGFP–-tubulin  (MCF7–GFP-tub).  Interest-
ingly, we observed colocalization of the MBs with microtubules 
in untreated cells (Fig. 3 B). This intriguing result prompted 
us to examine the spatial and temporal distribution of HIF-1 
mRNA after MB transfection in MCF7–GFP-tub cells. Live   
cell confocal microscopy revealed that HIF-1 MBs were dis-
persed throughout the cytoplasm and exhibited clear asso-
ciation with microtubules (Fig. 3 C). Furthermore, time-lapse 
imaging and particle tracking revealed microtubule-dependent 
movements of the MBs (Fig. 3 C and Videos 1 and 2). After 
2ME2 or TX treatment, the HIF-1 MBs were redistributed into 
larger cytoplasmic clusters and exhibited more constrained, 
nondirectional movements rather than the long-range traffick-
ing observed in untreated cells (Fig. 3 C and Videos 3 and 4). 
Notably, some HIF-1 MBs remained associated with TX- 
induced microtubule bundles; however, their movement was 
significantly compromised.
To  further  investigate  the  specificity  of  HIF-1  MB   
association with microtubules, we transfected MCF7–GFP-tub 
cells with a GAPDH-specific MB or a scrambled MB. No micro-
tubule colocalization or microtubule-dependent trafficking was 
Table I.  HIF-1 inhibition requires microtubule disruption
Cell line 1A9 1A9/PTX10 1A9 1A9/2MRC
Ctrl TX Ctrl TX Ctrl 2ME2 Ctrl 2ME2
HIF-1
  Untranslated 41.3 ± 0.6 71.0 ± 2.1 6.3 ± 1.5 4.5 ± 1.6 14.4 ± 1.5 52.9 ± 4.3 16.9 ± 2.2 17.5 ± 1.1
  Translated 58.7 ± 1.6 29.0 ± 2.1 93.7 ± 1.5 95.5 ± 1.6 85.6 ± 1.5 47.1 ± 4.3 83.1 ± 2.2 82.5 ± 1.1
GAPDH
  Untranslated 2.5 ± 1.1 6.8 ± 2.9 18.8 ± 2.5 15.5 ± 4.9 12.3 ± 1.5 12.6 ± 4.1 10.3 ± 1.1 4.5 ± 1.8
  Translated 97.5 ± 1.1 93.2 ± 2.9 81.2 ± 2.5 84.5 ± 4.9 87.7 ± 1.5 87.4 ± 4.1 89.7 ± 1.1 95.5 ± 1.8
Ctrl, control. Polysome association of HIF-1 and GAPDH mRNA in 1A9, 1A9/PTX10, and 1A9/2MRC cells. The percentage of translated versus untranslated mRNA 
is displayed as mean ± SEM (n = 2).JCB • VOLUME 192 • NUMBER 1 • 2011   88
Figure 3.  HIF-1 mRNA associates with cellular microtubules. (A) HIF-1 MBs incubated at 37°C for 1 h with a complementary (C) or sense (S) DNA ODN 
or total RNA from MCF7 cells. Relative fluorescence units (RFU) are represented as mean ± SEM. (B) MCF7–GFP-tub (white) cells fixed and processed for 
MB (red) hybridization. (zoom) Higher magnification views of the boxed area are shown. Two representative untreated cells are shown. (C) MCF7–GFP-tub 
(white) cells transfected with 100 nM HIF-1 MB (red) overnight, treated with 100 µM 2ME2 or 100 nM TX (1 h) and imaged continuously for 60 s. Arrows 
show inhibition of HIF-1 movement. (max) Stack arithmetic shows trajectory of MB movement. (max-zoom) Higher magnification view of max from boxed 
areas in the first column (Videos 1–4). (D) Anti-GFP was used to immunoprecipitate lysates from MCF7–GFP-tub cells treated overnight with 25 µM 2ME2 
or 25 nM TX. HIF-1, p53, and GAPDH mRNA expression are shown as mean fold change ± SEM (n = 3). Bars, 10 µm.89 Microtubule dynamics regulate HIF-1 translation • Carbonaro et al.
that 9% of total HIF-1 mRNA localized to P-bodies in con-
trol cells, whereas 64% and 70% of HIF-1 mRNA were found 
in  P-bodies  after  treatment  with  2ME2  or  TX,  respectively   
(Fig. 5 C). No association with Ago2 was seen for GAPDH or 
p53 mRNA (Fig. 5 A), and no change in the amount of total   
HIF-1,  p53,  or  GAPDH  mRNA  was  observed  upon  MTD 
treatment (Fig. S3 B) at concentrations that effectively down-
regulated HIF-1 protein levels (Fig. S3 A). To confirm the 
redistribution of HIF-1 mRNA into cytoplasmic P-bodies after 
MTD treatment in living cells, we transfected HeLa–GFP-Ago2 
cells with HIF-1 or GAPDH-specific MBs and performed con-
focal microscopy. MTD treatment induced significant colocal-
ization of HIF-1 MBs with Ago2-containing P-bodies, as we 
observed an 20% overlap of HIF-1 mRNA and Ago2 after 1 h 
or overnight treatment with 2ME2 or TX compared with 1% co-
localization in untreated cells (P < 0.001; Fig. 5 D). In contrast, 
no overlap was observed between Ago2 and GAPDH mRNA 
in either control or MTD-treated cells (unpublished data). 3D 
rendering of HIF-1 mRNA and Ago2 further revealed their 
overlap (Fig. 5 D and Videos 6 and 7). Together, these results 
demonstrate that disruption of microtubule dynamics triggers 
the accumulation of HIF-1 mRNA into cytoplasmic P-bodies 
for translational repression, suggesting that microtubule integ-
rity is required for active translation of HIF-1.
We next investigated whether restoration of microtubules 
can relieve the translational repression of HIF-1. To do so, we 
used the reversible microtubule depolymerizer Noc and moni-
tored P-body number after drug treatment and subsequent wash-
out. Noc treatment resulted in near-complete depolymerization 
accompanied by a profound increase in P-body number (Fig. 6 A).   
Noc was then removed, and cells were incubated in drug-free 
media for the indicated times. After drug washout, microtubule 
polymers were quickly reformed (within 1 h), and P-body num-
bers gradually decreased to the level observed in untreated cells 
(Fig. 6 A). Similar results were obtained in a parallel experiment 
in which single HeLa–GFP-Ago2 cells were followed over time   
though live cell imaging (Fig. S4 A). Again, a decrease in P-body   
number was evident after drug removal, suggesting that P-bodies   
disassemble and release repressed mRNAs once microtubules 
are reformed. To test this hypothesis, we monitored HIF-1 
protein expression after Noc washout. As expected, Noc treatment 
inhibited HIF-1 protein, whereas drug removal restored HIF-1 
protein (Fig. 6 B). To further confirm that HIF-1 mRNA 
returns  to  active  translation  after  microtubule  repolymeriza-
tion, we assessed HIF-1’s polysome association profile. We 
observed  that  HIF-1  translation  was  significantly  inhibited 
in Noc-treated cells and that this effect was reversed after drug 
washout and microtubule repolymerization (Fig. 6 C). These re-
sults are further corroborated by the accumulation of HIF-1 
mRNA into P-bodies after Noc treatment and its subsequent   
release from Ago2 after drug washout (Fig. 6 F). Together, these 
results indicate that, in concert with the microtubule cytoskeleton, 
P-bodies regulate HIF-1 translation and that HIF-1 mRNA 
can return to a translationally active state once the cellular stress 
of microtubule disruption is relieved.
To investigate the contribution of the P-body number in-
crease to HIF-1 translation repression, we used glucose starvation 
granules, both of which represent distinct cytoplasmic sites of 
translational repression (Ashe et al., 2000; Low et al., 2005). These 
data, together with our own observations, prompted us to inves-
tigate the potential involvement of P-bodies in the microtubule-
dependent repression of HIF-1 translation.
To visualize P-body formation in vivo, we used HeLa cells 
stably expressing the Argonaute family protein Ago2 fused to 
EGFP (HeLa–GFP-Ago2; Leung et al., 2006). Argonaute pro-
teins are major components of the miRNA machinery that local-
ize to P-bodies (Liu et al., 2005b; Sen and Blau, 2005). Live cell 
imaging of HeLa–GFP-Ago2 cells revealed distinct fluorescent 
particles of heterogeneous size in the cytoplasm of untreated   
cells. After treatment with the microtubule-depolymerizing agents 
2ME2 or nocodazole (Noc) or the stabilizing drug TX, we ob-
served a rapid and robust increase in the number of Ago2 foci per   
cell (Fig. 4 A). We confirmed that these Ago2 foci were P-bodies   
by immunostaining fixed samples with an antibody against   
GE-1/Hedls (human enhancer of decapping large subunit), a pro-
tein found exclusively in P-bodies, as opposed to other types of 
RNA-containing granules such as stress granules (Yu et al.,   
2005; Kedersha and Anderson, 2007). Visualization of cytoplasmic   
GE-1 and Ago2 revealed that 100% of Ago2 foci colocalized   
with GE-1 (Fig. 4 B, arrows). Importantly, P-body quantifica-
tion revealed a significant increase after MTD treatment at con-
centrations that effectively disrupted microtubules and inhibited 
HIF-1 protein expression (Fig. 4, B and D). Specifically, 80% 
of untreated cells contained three or less P-bodies, whereas >70% 
of cells contained more than three P-bodies upon 2ME2 or TX 
treatment (Fig. 4 C). Although we arbitrarily used a cutoff of 
three P-bodies per cell, many MTD-treated cells contained >40 
P-bodies. This change in P-body number is not because of an in-
crease in Ago2 or GE-1 protein levels (Fig. 4 D).
To determine whether the increase in P-body formation is 
specific to disruption of the microtubule cytoskeleton or whether 
it could result from more general cytoskeletal stress, we used 
the actin-depolymerizing agent cytochalasin D. Actin depoly-
merization did not affect P-body number (Fig. 4 C), suggesting 
that this effect was specific to disruption of microtubules. Con-
sistent with this result, cytochalasin D treatment had no effect 
on HIF-1 protein levels (Fig. 4 D).
HIF-1 mRNA reversibly accumulates in  
P-bodies after microtubule disruption
Thus far, we have shown that disruption of microtubule dy-
namics inhibits HIF-1 translation, redistributes HIF-1 MBs 
into larger cytoplasmic foci, and stimulates P-body formation   
(Figs. 1, 3, and 5). To examine whether microtubule stabilization   
or depolymerization sequesters HIF-1 mRNA into P-bodies,   
we immunoprecipitated Ago2 protein, extracted bound mRNAs, 
and performed qRT-PCR for HIF-1, GAPDH, and p53. TX 
and 2ME2 treatment resulted in 17-fold and 12-fold increases, 
respectively, in the amount of HIF-1 mRNA associated with 
Ago2 compared with untreated cells (Fig. 5 A, bottom). A con-
comitant decrease in HIF-1 mRNA isolated from the non-
Ago2–bound fraction was also observed (Fig. 5 B), further 
confirming  the  significant  enrichment  of  HIF-1  mRNA  in 
P-bodies  after  MTD  treatment.  More  specifically,  we  found JCB • VOLUME 192 • NUMBER 1 • 2011   90
Figure 4.  MTDs induce P-body formation. (A) Live cell imaging of HeLa–GFP-Ago2 cells treated with 100 µM 2ME2, 1 µM TX, or 30 µM Noc for 1 h.   
(B) HeLa–GFP-Ago2 (green) cells treated with 25 µM 2ME2 or 50 nM TX overnight, fixed, and stained for GE-1 (red) and -tubulin (white). Arrows show 
colocalization of Ago2 and GE-1. (C) The number of Ago2 foci per cell was quantified (100 cells/condition) and plotted as percentage of cells with either 
three or less or more than three P-bodies (mean ± SEM; n = 3; **, P < 0.01). (D) Immunoblot of HeLa–GFP-Ago2 cells treated as in B and followed by 4-h 
hypoxia. Bars, 10 µm.91 Microtubule dynamics regulate HIF-1 translation • Carbonaro et al.
Figure 5.  HIF-1 mRNA is sequestered to P-bodies upon microtubule disruption. (A) HeLa–GFP-Ago2 cells treated with 25 µM 2ME2 or 25 nM TX over-
night, lysed, and immunoprecipitated (IP) using an anti-GFP antibody. Ago2 protein was detected by immunoblotting. Ago2-bound RNA was extracted, 
and HIF-1, p53, and GAPDH expression is displayed as mean fold change ± SEM (n = 3; *, P < 0.05). (B) RNA from Ago2 unbound lysates was 
processed as in A (n = 3; *, P < 0.05). (C) Bar graph showing the percentage of HIF-1 mRNA localized to P-bodies after the indicated drug treatments.   
(D) HeLa–GFP-Ago2 cells transfected with 100 nM HIF-1 MB (red) and treated with 100 nM TX or 100 µM 2ME2 for 1 h. Bar, 10 µm. Right column shows 
the percentage of overlap (mean ± SEM; n = 3) between Ago2 foci and HIF-1 MB (***, P < 0.001; Videos 6 and 7).JCB • VOLUME 192 • NUMBER 1 • 2011   92
Figure 6.  HIF-1 translation inhibition is reversed after microtubule repolymerization. (A) HeLa–GFP-Ago2 (green) cells treated with 10 µM Noc for 6 h   
followed by drug washout (W/O). Cells were fixed at the indicated times and immunostained for -tubulin (white). The percentage of cells with either three 
or less or more than three P-bodies is plotted (mean ± SEM; n = 10 fields of view/condition). (B) HIF-1 and actin protein levels in HeLa–GFP-Ago2 cells 
treated with 1 µM Noc overnight and lysed after 6-h washout (6) or continued drug treatment () with 4-h hypoxia. (C) The percentage of HIF-1 mRNA 
associated with untranslating fractions (1_6) or actively translating polysomes (7_12) after 1 µM Noc treatment overnight and 6 h drug washout is plotted 
(mean ± SEM; n = 3; *, P < 0.05). (D) HeLa–GFP-Ago2 cells were incubated in glucose-free media for 1 h and stained for -tubulin (white). The percentage 
of cells with three or less or more than three P-bodies (mean ± SEM; n = 3; *, P < 0.05) is plotted. (E) Immunoblot of HIF-1 and actin after 1-h glucose 
starvation and 4-h hypoxia. (F) Ago2-bound RNA extracted from control (Ctrl), glucose-starved (1 h) cells, or cells treated overnight with 1 µM Noc (Noc) 
and followed by 6-h washout. HIF-1 expression was quantified by qRT-PCR (mean ± SEM; n = 2). Bars, 10 µm.93 Microtubule dynamics regulate HIF-1 translation • Carbonaro et al.
luciferase reporter and monitored TX’s effect on its activity.   
TX treatment inhibited HIF 3 UTR luciferase activity, as did co-
transfection of the HIF-targeting miRs both alone and together 
with TX (Fig. 8 B). Importantly, inhibition of the endogenous 
HIF-targeting miRNAs after transfection with HIF-specific anti-
miRs counteracted TX’s effect and restored luciferase activity   
(Fig. 8 B). To examine the effect of HIF-specific anti-miRs on   
HIF-1 protein expression, we transfected cells with a com-
bination of anti-miRs and assessed HIF-1 by immunoblotting. 
Although transfection of each individual anti-miR did not signifi-
cantly affect TX’s activity, transfection of all four HIF-specific 
anti-miRs  together  almost  completely  abrogated  TX’s  abil-
ity to inhibit HIF-1 protein (Fig. 8 C). Interestingly, inhibi-
tion of two miRNAs not predicted to target HIF-1, namely 
hsa-miR-Let7a  and  hsa-miR-545,  had  no  effect  on  the  TX- 
induced translational inhibition of HIF-1 (Fig. 8 C), although 
MTD treatment enhanced their binding to Ago2 (Fig. 7 C).   
Together, these results demonstrate that miRNA targeting of 
HIF-1’s 3 UTR plays a critical role in the microtubule- 
dependent regulation of HIF-1.
We next sought to elucidate the role of Ago2 in the regula-
tion of HIF-1 translation. To do so, we generated HeLa cells 
stably expressing Ago2 shRNA and confirmed KD by qRT-PCR 
(Fig. 9 A) and immunofluorescence staining (Fig. 9 C, top).   
Interestingly, TX treatment was unable to inhibit HIF-1 protein 
in Ago2 KD cells in contrast to the effective inhibition observed 
in control or mock-transfected cells (Fig. 9 B). This result was 
confirmed by transient KD of Ago2 using Ago2-specific siRNAs 
(unpublished data). Notably, although HIF-1 was not affected 
by TX treatment in Ago2 KD cells, P-body number (detected by 
GE-1 immunostaining) was still increased (Fig. 9 C).
Discussion
The importance of HIF-1 in the pathophysiology of cancer, 
cardiovascular  disease,  and  other  ischemic  conditions  has 
placed considerable interest in understanding HIF-1 regu-
lation. Although most studies address the pathways involved 
in  HIF-1  protein  degradation,  the  mechanisms  regulating   
HIF-1 translation remain unclear. In addition, current knowl-
edge of HIF-1 translation stems from studies focusing on the 
mechanisms that enable continued translation of HIF-1 under 
hypoxia (Lang et al., 2002; Schepens et al., 2005); however, 
mechanisms involved in the repression of HIF-1 translation 
have not been identified.
In this study, we report a new mechanism of cytoskeletal- 
mediated repression of HIF-1 translation. Our studies demon-
strate that microtubule integrity is critical for efficient translation   
of HIF-1, as HIF mRNA binds to and traffics on dynamic   
microtubules, presumably to sites of active translation (Fig. 3 
and Videos 1–4). Our results are the first to show that the fate   
of an mRNA encoding a transcription factor is tightly reg-
ulated by the microtubule cytoskeleton. We show that col-
lapse of the microtubule network by MTDs is detrimental for   
HIF-1 translation, as it triggers the release of HIF-1 mRNA 
from polysomes and recruitment to P-bodies (Figs. 1 and 5) 
where translationally silenced mRNA is stored and/or degraded 
to increase P-body number independently of disruption of micro-
tubule dynamics (Teixeira et al., 2005). As expected, glucose 
starvation (1 h or overnight) induced a rapid increase in P-body   
number without affecting microtubules (Fig. 6 D). However, there 
was no inhibition of HIF-1 protein (Fig. 6 E and Fig. S4 B)   
nor any change in the amount of HIF-1 mRNA bound to Ago2 
after glucose starvation (Fig. 6 F). Together, these results dem-
onstrate that P-body formation alone is not sufficient to inhibit 
HIF-1 translation but, rather, that perturbation of the micro-
tubule cytoskeleton is required to trigger the accumulation of 
HIF-1 mRNA into these cytoplasmic sites of translational re-
pression. Importantly, we show that microtubules exert a tight, 
reversible control over these processes.
MTD treatment enhances the binding of 
HIF-1–targeting miRNAs to Ago2
P-bodies are known hubs for miRNAs, which are short, noncod-
ing regulatory RNAs that repress translation upon binding to their 
target mRNA sequence (Pillai, 2005; Tomari and Zamore, 2005). 
Though the exact mechanism of miRNA-mediated transla-
tional repression is not well elucidated, several studies have shown 
that Argonaute proteins, miRNAs, and their target mRNAs all 
accumulate in P-bodies (Liu et al., 2005b; Pillai et al., 2005; 
Sen and Blau, 2005). Thus, we hypothesized that sequestra-
tion of HIF-1 mRNA to Ago2 after stabilization or depolymer-
ization  of  microtubules  facilitates  its  interaction  with  specific 
miRNAs that, in turn, inhibit its translation. Using the miRBase   
Targets database (Sanger Institute), we identified nine miRNAs 
predicted to target the 3 UTR of human HIF-1. Transfection 
of specific premiRs (miRNA mimics) into HeLa or MCF7   
cells (not depicted) resulted in down-regulation of HIF-1 protein 
(Fig. 7 A) without affecting HIF-1 transcription (Fig. 7 B). 
This result is consistent with the predicted role of miRNAs in 
the repression of HIF-1 translation.
To examine whether MTD treatment affects the P-body   
localization of HIF-targeting miRNAs, we immunoprecipitated 
Ago2 and quantified the relative abundance of associated miRNAs. 
This analysis revealed an increase in the amount of Ago2- 
bound HIF-targeting miRNAs after either TX or Noc treatment 
(Fig. 7 C). Repolymerization of microtubules after Noc washout 
resulted in dissociation of HIF-targeting miRNAs from Ago2, 
further implicating these miRNAs in the regulation of HIF-1 
translation (Fig. 7 C). In addition, glucose starvation did not in-
duce miRNA association with Ago2, suggesting that the mere 
increase in P-body number is not sufficient to recruit HIF-targeting 
miRNAs to Ago2 (Fig. 7 C). Finally, there was no significant in-
crease in the level of total miRNAs observed after drug-induced 
microtubule stabilization or depolymerization (Fig. 7 D).
Our data showing miRNA enrichment to P-bodies sug-
gested that the 3 UTR of HIF-1 plays an important role in its 
translational regulation. To test this hypothesis, we transfected 
HeLa cells with a construct encoding GFP-tagged HIF-1 cDNA 
lacking its UTRs. TX treatment had no effect on the exogenous 
HIF-1 protein, whereas it efficiently down-regulated endog-
enous HIF-1 protein (Fig. 8 A). This result indicated that the   
TX-induced suppression of HIF-1 requires the presence of 
HIF’s UTRs. Next, we transfected cells with a HIF-1 3 UTR   JCB • VOLUME 192 • NUMBER 1 • 2011   94
Figure 7.  Role of HIF-1–targeting miRNAs in the microtubule-dependent translation of HIF-1. (A) HIF-1 immunoblot of MCF7 cells transfected with 
each pre-miR, a combination of all four, or a Cy3-labeled negative control (Cy3 Ctrl) and treated with 10 µM proteasome inhibitor MG-132 for 4 h.   
(B) HIF-1 mRNA expression quantified by qRT-PCR after transfection of all HIF-targeting miRNAs (miRs) in combination (mean ± SEM; n = 2). (C) Relative ex-
pression of Ago2-bound miRNAs quantified by qRT-PCR from HeLa–GFP-Ago2 cells treated overnight with 25 nM TX, glucose starvation (left; mean ± SEM; 
n = 3), or 1 µM Noc followed by a 6-h drug washout (right; mean ± SEM; n = 2, *, P < 0.05; **, P < 0.01). (D) Endogenous miRNA expression was 
assessed by qRT-PCR in HeLa cells after overnight treatment with 25 nM TX or 25 µM 2ME2.95 Microtubule dynamics regulate HIF-1 translation • Carbonaro et al.
studies in yeast and mammalian cells (Sweet et al., 2007; Aizer   
et al., 2008). Other cellular stressors such as nutrient deprivation 
and glucose starvation have been associated with an increase in 
P-body number. Although this increase could be interpreted as a 
cell’s defense mechanism to cope with environmental stress by 
shutting down translation, we demonstrate that the mere increase 
in P-body number had no effect on HIF-1 translation, suggest-
ing that disruption of microtubule dynamics is the critical initiat-
ing step in the repression of HIF translation. In spite of these data, 
what remains puzzling is the exact signaling cascade that links 
microtubule stabilization or destabilization with recruitment of 
HIF-1 mRNA and HIF-targeting miRNAs to P-bodies. In this 
study, we show that one important component of this cascade   
is Ago2, as its depletion prevented TX’s effect on HIF translation 
(Fig. 9), although microtubules were efficiently stabilized (not 
depicted). TX also led to an increase in P-body number in Ago2 
KD cells as a result of microtubule hyperstabilization.
P-bodies are known hubs for miRNAs, which function in 
association with Argonaute family proteins and other components 
(Anderson and Kedersha, 2002; Kedersha and Anderson, 2002; 
Cougot et al., 2004; Andrei et al., 2005; Brengues et al., 2005; 
Kedersha et al., 2005; Teixeira et al., 2005). However, the sig-
nals that lead to recruitment of specific messages to P-bodies 
are not well understood. Our data reveal dynamic shuttling of 
HIF-1 mRNA from polysomes to P-bodies in a microtubule-
dependent manner (Figs. 5 and 6). A similar dynamic exchange 
between P-bodies and polysomes has been reported for CAT-1 
mRNA where glucose starvation released CAT-1 mRNA from 
P-bodies and enabled its recruitment to polysomes (Bhattacharyya 
et al., 2006). Although the role of the microtubule network was 
not addressed in that study, it would be interesting to investigate 
its involvement in the exchange of mRNAs between P-bodies 
and polysomes. It is currently unknown how different types of 
cellular stress regulate translation by recruitment or release of 
specific messages to and from P-bodies and which additional 
mRNAs are susceptible to microtubule control.
We also showed that microtubule disruption led to an in-
crease in the number of P-bodies, in agreement with previous 
Figure 8.  TX requires the 3 UTR of HIF-1 to regulate its translation. (A) HeLa–GFP-Ago2 cells transfected (3:1 or 3:2 Fugene/DNA ratio) with a GFP-
tagged HIF-1 construct lacking both the 5 and 3 UTR (HIF-1–GFP) and treated with 25 nM TX overnight. (B) HeLa–GFP-Ago2 cells transfected with a HIF-1 
3 UTR luciferase expression vector either alone or cotransfected with four HIF-targeting miRNAs (miR), four HIF-specific anti-miRs (anti), or a scrambled 
miRNA-like sequence (Scram). Luciferase activity was measured in untreated or TX-treated cells as indicated. *, P < 0.05. Error bars indicate mean ± SEM. 
(C) HIF-1 immunoblot of HeLa–GFP-Ago2 cells transfected with HIF-specific anti-miRs (622, 338, 411, and 519b), a combination of all four, or Cy3 control 
for 24 h followed by overnight 25 nM TX treatment. Transfection of two non-HIF–related anti-miRs (let7a and 545) was used as a control.JCB • VOLUME 192 • NUMBER 1 • 2011   96
model, mRNAs accumulate in P-bodies regardless of prior 
miRNA coupling, and translation is suppressed as the result of 
ribosome exclusion (Andrei et al., 2005; Teixeira et al., 2005). 
Our Ago2 KD results support the first model whereby Ago2 
mediates  the  association  between  HIF-1  mRNA  and  HIF- 
targeting miRNAs in the cytoplasm after microtubule disrup-
tion and subsequently targets these complexes into P-bodies for 
translational repression.
The findings presented in this study, together with recent 
data from our laboratory showing that HIF-1 protein also 
of RNA-induced silencing complexes (Liu et al., 2005a; Meister   
et al., 2005; Sen and Blau, 2005) to suppress translation. 
However, the contribution of different P-body components in 
this process is not well understood. Moreover, it remains un-
clear  whether  HIF-1  mRNA  interacts  with  miRNAs  after 
its entry into P-bodies or is first targeted by miRNAs in the   
cytoplasm. Previous studies have proposed two general models 
of P-body–mediated translational repression. The first proposes 
that formation of the mRNA–miRNA complex occurs before 
P-body localization (Liu et al., 2005b), whereas in the second 
Figure 9.  Ago2 is necessary for MTD-induced inhibition of HIF-1 translation. (A) Ago2 mRNA expression by qRT-PCR after stable expression of Ago2 
(shRNA; mean ± SEM; n = 2; ***, P < 0.001) or control shRNA (Neg Ctrl). (B) Immunoblot of HeLa cells transfected as in A and treated with 25 nM TX 
overnight. (right) A more intense scan of lanes 5 and 6 is depicted as a result of sample underloading. (C) Ago2-GFP is visualized in fixed untreated or 
TX-treated HeLa–GFP-Ago2 cells transfected with Ago2 siRNA (top) and stained for GE-1 (bottom). Bar, 10 µm.97 Microtubule dynamics regulate HIF-1 translation • Carbonaro et al.
Cells were fixed with PHEMO buffer (0.068 M Pipes, 0.025 M Hepes, 
0.015 M EGTA, 0.003 M MgCl2, and 10% DMSO, pH 6.8) containing 
3.7% formaldehyde, 0.05% glutaraldehyde, and 0.5% Triton X-100 for 
10 min at room temperature. Coverslips were blocked in 10% goat serum 
in PBS for 10 min and processed for double-labeling immunofluorescence 
with rat anti–-tubulin, mouse anti–HIF-1, and mouse anti–GE-1 primary 
antibodies followed by Alexa Fluor 488, 586, and 647 secondary anti-
bodies. Coverslips were then mounted onto glass slides and imaged with a 
confocal microscope (5 LIVE; Carl Zeiss, Inc.) using AIM software (version 
4.2; Carl Zeiss, Inc.) and a 100× 1.4 NA Plan Apochromat objective.
MB design and live cell imaging
HIF-1 MB, 5-Texas red–TCACCAGCATCCAGAAGTGGTGA–Blackhole 
quencher 2 (BHQ2)-3; scrambled MB, 5-Texas red–TCACCACTTCTG-
GATGCTGGTGA-BHQ2-3;  and  GAPDH  MB,  5-Texas  Red–CGACGG-
AGTCCTTCCACGATACCACGTCG-BHQ2-3 (Eurofins MWG Operon). 
Fluorescence intensity was read with a microplate spectrofluorometer 
(Gemini EM; MDS Analytical Technologies). For live cell imaging, MBs 
were transfected (Oligofectamine; Invitrogen) for 24 h. Images were ac-
quired by continuous scanning with a confocal (5 LIVE; AIM 4.2 software) 
or  spinning-disk  confocal  microscope  (Ultraview  ERS  software;  Perkin-
Elmer) using a 100× 1.4 NA Plan Apochromat objective and a camera 
(Orca-ER; Hamamatsu Photonics). A Tokai Hit heating stage (Shizuoka-ken; 
418–0074 Japan) was used to incubate cells at 37°C with 5% CO2 in 
DME without l-glutamine and phenol red (Cellgro). Stack arithmetic and 3D 
reconstructions were performed using MetaMorph software (MDS Analyti-
cal Technologies).
Linear sucrose gradient fractionation
The polysome profile analyses were performed after linear sucrose gra-
dient  (LSG)  fractionation  as  previously  described  (Feng  et  al.,  1997).   
In brief, cells were washed with PBS containing 100 µg/ml cycloheximide 
and lysed with 500 µl LSG lysis buffer (100 mM KCl, 20 mM Tris, pH 7.5,   
5 mM MgCl2, 0.4% NP-40, 100 µg/ml cycloheximide, 0.1 U RNasin, and 
complete mini-EDTA–free protease inhibitors [Roche]). Cell lysates were 
precleared by centrifugation at 14,000 rpm for 15 min at 4°C. The super-
natant was loaded onto 15–45% sucrose gradients (in a buffer containing 
5 mM MgCl2, 80 mM NaCl, and 20 mM Tris-HCl, pH 7.5). Ultracentrifu-
gation (36,000 rpm for 1.5 h at 4°C) was performed in an SW41 rotor. 
12 equal-volume (1 ml) fractions were collected with continuous OD254 
measurements (Vis Detector UA-6; Isco UV). Total RNA was isolated from 
each fraction using RNeasy kit (QIAGEN). cDNA was synthesized with the 
ProtoScript First Strand cDNA Synthesis kit (New England BioLabs, Inc.). 
qRT-PCR was performed using iQ SYBR green supermix (Bio-Rad Laborato-
ries) and the following specific primers: HIF-1 (forward, 5-TGGTGACAT-
GATTTACATTTCTGA-3; reverse, 5-AAGGCCATTTCTGTGTGTAAGC-3), 
GAPDH (forward, 5-GGAGTCAACGGATTTGGTCG-3; reverse, 5-CTTG-
ATTTTGGAGGGATCTCG-3), or p53 (forward, 5-TCACAGCACATGAC-
GGAGGTT-3; reverse, 5-TCGGATAAGATGCTGAGGAGG-3).
shNA and siRNA transfection
SureSilencing shNA plasmids for human EIF2C2 (Ago2) used for Ago2 KD 
were obtained from SABiosciences. Cells were transfected with 0.40 µg 
shNA using FuGENE 6 transfection reagent (Roche) for 48 h followed by 
puromycin selection to generate stable transfections. Silencer select pre-
designed siRNAs were obtained from Applied Biosystems (siRNA ID nos. 
25935, s25930, and s25931). Cells were transfected with 10 nM of each 
siRNA for 48 h using the AMAXA nucleofector system (Lonza).
Immunoprecipitation of mRNPs
RNA  isolation  after  GFP  immunoprecipitation  was  performed  as  de-
scribed previously (Tenenbaum et al., 2002). In brief, cells were lysed 
in polysome lysis buffer (100 mM KCl, 5 mM MgCl2, 10 mM Hepes,   
pH 7.0, 0.5% Nonidet P-40, 1 mM DTT, 100 U/ml RNase OUT, 0.2 mM 
PMSF, and complete mini-EDTA–free protease inhibitors) and subjected to 
immunoprecipitation using rabbit anti-GFP antibody (Novus Biologicals), 
or ChomPure rabbit IgG control (Jackson ImmunoResearch Laboratories, 
Inc.) bound to protein A agarose beads (EMD) in NT2 buffer (50 mM 
Tris, pH 7.4, 150 mM NaCl, 1 mM MgCl2, and 0.05% Nonidet P-40) for   
2 h. Beads were washed five times in NT2 buffer, resuspended in 100 µl 
NT2 buffer supplemented with 0.1% SDS and 30 µg proteinase K, and 
incubated at 55°C for 30 min. Bound and unbound RNA was extracted, 
converted to cDNA, and subjected to qRT-PCR as described above. The 
percentage of HIF-1 mRNA in P-bodies was calculated as follows: per-
centage of Ago2-bound HIF-1 mRNA = (Ago2-bound mRNA/[bound + 
unbound mRNA]) × 100.
binds microtubules (unpublished data), raise the possibility that   
HIF-1 translation may physically occur on microtubules. In sup-
port of this hypothesis, many proteins that regulate translation, 
including eukaryotic initiation and elongation factors (eEF-1, 
eEF-1-2, eIF-2, eIF-3, eIF-4a, eIF-4E, and eIF-5), have been 
shown to associate with microtubules (Jansen, 2001; López 
de Heredia and Jansen, 2004). Although the role of microtubules 
in mRNA transport and/or anchoring is well established, especially 
in neurons (Palacios and St Johnston, 2001; López de Heredia and 
Jansen, 2004), their involvement in protein translation remains 
unclear. Interestingly, we showed that two non-HIF–related 
miRNAs were also recruited to Ago2 after disruption of micro-
tubule dynamics (Fig. 7 C), suggesting that additional messages 
may be susceptible to MTD treatment. Identification of proteins 
that mediate the association of HIF-1 mRNA with microtubules 
can provide new therapeutic opportunities to specifically target 
HIF translation for cancer therapy.
In summary, our work identifies an important, as of yet 
unrecognized, role of the microtubule cytoskeleton in repress-
ing HIF-1 translation and provides compelling evidence that 
microtubules are actively involved in regulating protein trans-
lation. Understanding the role of microtubules in both the facili-
tation and repression of HIF-1 translation will have important 
implications for both cell biology and clinical oncology given 
the importance of the microtubule cytoskeleton and HIF-1 in 
tumor biology.
Materials and methods
Chemicals and antibodies
Vinblastine and MG-132 were obtained from EMD, and paclitaxel was 
obtained from Sigma-Aldrich. 2ME2 was provided by EntreMed Inc. Pri-
mary antibodies used were rat anti–-tubulin (YL1/2; EMD), mouse anti–
HIF-1 (BD), rabbit anti-actin (Sigma-Aldrich), mouse anti–GE-1 (sc-8418; 
Santa Cruz Biotechnology, Inc.), mouse anti-Ago2 (Abcam), sheep anti-
p53 (Ab7; Oncogene Science), and mouse anti-GAPDH (6C5; Santa Cruz 
Biotechnology, Inc.). The following secondary antibodies were used for   
immunofluorescence: Alexa Fluor 488, 568, and 647, and rhodamine 
phalloidin (Invitrogen). The following secondary antibodies were used 
for immunoblotting: Alexa Fluor 680 (Invitrogen) and IRDye 800CW– 
conjugated antibodies (Rockland Immunochemicals, Inc.).
Cell lines
The cell lines used in this study were MCF7 human breast cancer cells stably 
expressing EGFP-tubulin (provided by M. Jordan, University of California, 
Santa  Barbara,  Santa  Barbara,  CA),  MCF7  cells  stably  expressing  GFP- 
nucleolin (provided by M. Kastan, St. Jude Children’s Research Hospital,   
Memphis, TN), and HeLa human cervical carcinoma cells stably expressing 
EGFP-Ago2 (provided by P. Sharp, Massachusetts Institute of Technology, Cam-
bridge, MA), all maintained in DME (Cellgro; Mediatech, Inc.). 1A9 human   
ovarian carcinoma, 1A9/PTX10 (Giannakakou et al., 1997), and 1A9/
2MRC (Escuin et al., 2009) cells were cultured in RPMI1640 (Cellgro). For 
hypoxic exposure, cells were sealed in a modular incubator chamber (Billups-
Rothenberg, Inc.) and flushed with 1% O2, 5% CO2, and 94% N2 for 4 h.
Western blotting
Proteins (70 µg/lane) were resolved by SDS-PAGE, electrotransferred to PVDF 
transfer membranes (Immobilon; Millipore), and incubated with the indicated 
primary  antibodies  followed  by  fluorescence-conjugated  secondary  anti-
bodies. Immunoreactivity was visualized using an infrared imaging system 
(Odyssey; LI-COR Biosciences). Protein quantification was performed using 
Odyssey (version 2.1) and ImageJ (National Institutes of Health) software.
Immunofluorescence and confocal microscopy
Exponentially growing cells were plated on 12-mm glass coverslips (Thermo 
Fisher Scientific) into 24-well plates and treated with the indicated drugs. JCB • VOLUME 192 • NUMBER 1 • 2011   98
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GFP-bound miRNA isolation and miRNA validation
miRNAs were isolated from total cell lysates or Ago2-bound fractions using 
the mirVana miRNA Isolation kit (Ambion). cDNA was synthesized using 
the MicroRNA Reverse Transcription kit (TaqMan), and qRT-PCR was per-
formed using miRNA (TaqMan). Primers specific for each miRNA were ob-
tained from Applied Biosystems. All values were normalized to expression 
of the small nucleolar RNA U19. Pre-miR miRNA precursor molecules and 
anti-miR miRNA inhibitors were obtained from Applied Biosystems and 
transfected into cells at 10 nmol/liter using FuGENE 6 (Roche) for 48 h.
Luciferase assay with HIF-1 3 UTR
A pHIF1-luc-3-UTR construct (provided by G. Semenza, Johns Hopkins Uni-
versity, Baltimore, MD) was cotransfected into cells with the pre-miR miRNA 
precursors or anti-miRs for 24 h. The ratio of firefly to renilla luciferase was 
monitored after each condition using the Dual-Luciferase Reporter Assay Sys-
tem (Promega) and a Sirius Tube Luminometer (Berthold Detection Systems).
Statistical analyses
The p-values for altered translation status (Fig. 1 B) and increased P-body 
numbers (Fig. 4 C) were calculated using one-way analysis of variance   
followed by multiple comparisons with Bonferroni adjustments. P-values   
for Ago2-enriched transcripts (Fig. 5, A and B) were obtained using the 
Wilcoxon sum-rank test, and the Kruskal-Wallis test was used to calculate 
the p-value for HIF-MB/Ago2 colocalization. A t test was used to determine 
the p-value for increased P-body number after glucose starvation (Fig. 6 C) 
and for Ago2-enriched miRNAs (Fig. 7 C). A t test was also used to deter-
mine p-values for fold change in luciferase activity (Fig. 8 B) and Ago2 ex-
pression (Fig. 9 A). All statistical analyses were performed using Stata for 
Windows (release 10).
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Fig. S1 shows the state of microtubules in the 2ME2- and TX-resistant cell 
lines after each drug treatment. Fig. S2 shows MB design and controls con-
firming that GAPDH or antisense MBs do not associate with microtubules. 
Fig. S3 shows a parallel Western blot and qRT-PCR (Fig. 5), confirming that 
2ME2 and TX treatment inhibit HIF-1 protein without affecting total RNA 
levels. Fig. S4 shows time-lapse confocal microscopy of a single cell after   
Noc treatment and washout. Videos 1–4 show microtubule-dependent 
trafficking of HIF-1 mRNA in untreated (Videos 1 and 2), 2ME2 (Video 3)-, 
or TX (Video 4)-treated cells. Video 5 shows lack of microtubule-dependent   
trafficking of GAPDH mRNA. Videos 6 and 7 show 3D models of HIF-1   
accumulation  into  Ago2  foci  after  2ME2  and  TX  treatment,  respectively.   
Online  supplemental  material  is  available  at  http://www.jcb.org/cgi/ 
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